Rennova Health Inc (RNVA)

[nfrequent]

Big bucks. The SEC has all the info we have and more, and RNVA is still pink. I've tracked the earnings reports since Rennova received the CAH certification which dramatically revenue/cost ratios. Based on the startup timelines, Myrtle could not have reached breakeven until late in Q4 at the earliest. In other words, RNVA (Rennova Healthcare CAH) is on track to reach $12 million in 2024 earnings even on a flat trendline. Anybody who does their DD at this point and doesn't buy RNVA will regret it.